吉西他滨顺铂联合索拉非尼或安慰剂一线治疗晚期非小细胞肺癌的随机对照研究

BACKGROUND AND OBJECTIVE: Platinum-based chemotherapy doublets reached an efficacy plateau in nonsmall- cell lung cancer (NSCLC). This randomized controlled study prospectively assessed the efficacy and safety of cisplatin plus gemcitabine with either Sorafenib or placebo as first-line therapy for N...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
临床研究
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999653/
https://www.ncbi.nlm.nih.gov/pubmed/21426666
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.03.10

Ejemplares similares

Ejemplares similares